ME/CFS with brain fog and cannot move, somewhat better on fexofenadine and famotidine
- Condition
- ME/CFS
- At worst
- Not stated
- Ill before improving or writing
- Not stated
- Last post
- Apr 2026
In their words
- Condition: ME/CFS
I’m in a similar boat today. Tried slow walking and light weightlifting and clearly overdid it because now I cannot move.
In context ↗ - Now: Somewhat better
I’ve been taking the combo for about a week, and until my work out slip up today, I have been feeling lighter, having much less brain fog, and some of my motivation has returned.
In context ↗
Read from 1 of their posts and comments; links to the one this page draws on
Summary
A person with CFS tried slow walking and light weightlifting, overdid it, and now cannot move. For about a week they took fexofenadine with famotidine for high histamine and felt lighter, with much less brain fog and more motivation, until a workout slip-up set off a flare; they hoped the combination would help it.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- fexofenadine · Helped
I’ve been taking the combo for about a week, and until my work out slip up today, I have been feeling lighter, having much less brain fog, and some of my motivation has returned.
In context ↗ - slow walking and light weightlifting · Worse
Tried slow walking and light weightlifting and clearly overdid it because now I cannot move.
In context ↗
Approaches: H1 antihistamines · H2 blockers
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, in the order they describe; they don’t give enough times to place each step. Hover or tap a point. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| — | limited activity at baseline, with brain fog and low motivationI’m in a similar boat today.In context ↗ | Moderate | |
| about a week into fexofenadine and famotidine | felt lighter, less brain fog, motivation returningI have been feeling lighter, having much less brain fog, and some of my motivation has returned.In context ↗ | Mild | Fexofenadine (Allegra) |
| 2026-04-28 | crashed after slow walking and light weightliftingTried slow walking and light weightlifting and clearly overdid it because now I cannot move.In context ↗ | Moderate | |
| 2026-04-28 | in a flare, waiting to see if the antihistamine combo helpsI’m interested to see what it does to help this latest flare up.In context ↗ | Moderate |
Symptoms mentioned
Their words about their symptoms
- Post-exertional malaise
Tried slow walking and light weightlifting and clearly overdid it because now I cannot move.
In context ↗ - Brain fog
having much less brain fog
In context ↗
Ask Miruvor AI
Similar stories
-
Long COVID at its worst mostly lying down, now nearly back to normal with Zepbound
Ill with long COVID from July 2024; at worst sleeping or lying down most of the day, barely functioning, with fatigue, PEM, brain fog, palpitations and POTS. Antihistamines and supplements raised energy within a week, and nattokinase, bromelain and curcumin…
-
Bedbound with severe ME/CFS, now moving toward moderate with pacing and LDN
Ill with ME/CFS since a viral infection at age 8 in 2012, they fluctuated between mild and moderate/severe for over a decade. A virus in early 2025 dropped them from near remission to severe and bedbound, with worse POTS and suspected MCAS. Low-dose…
-
Mostly housebound with ME/CFS, now somewhat better after treating MCAS and SIBO
Cove 66196 fell ill with an acute onset at the end of 2017, aged 27, and was mostly housebound after a relapse tied to MCAS by 2021, with later hospitalisations from a severe relapse. Antivirals taken for cold sores did nothing for his ME/CFS and upset his…
-
Bedbound with ME/CFS after COVID, some improvement with low-dose naltrexone and ivabradine
She had 15 years of gradual ME/CFS symptoms with teenage EBV and crashes during her PhD, then became bedbound after COVID in early 2024. Diagnosed with ME/CFS, POTS, MCAS and hEDS in 2025, she credits low-dose naltrexone, ivabradine, H1/H2 antihistamines and…